Adma Biologics (ADMA)

$17.81 +0.82 (4.83%)
Market Cap 4.05B
Revenue (ttm) 426.45M
Net Income (ttm) 197.67M
EPS (ttm) N/A
PE Ratio 29.26
Forward PE 26.94
Profit Margin 46.35%
Debt to Equity Ratio 0.18
Volume 1,284,105
Avg Vol 3,248,636
Day's Range N/A - N/A
Shares Out 238.63M
Stochastic %K 44%
Beta 0.38
Analysts Strong Sell
Price Target $32.33

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute e...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
Curtfry22
Curtfry22 Aug. 18 at 5:15 PM
$ADMA
1 · Reply
baston
baston Aug. 18 at 4:51 PM
$ADMA
0 · Reply
huma_44
huma_44 Aug. 18 at 2:10 PM
$ADMA added, so cheap after a great ER
0 · Reply
biffermeister
biffermeister Aug. 18 at 2:01 PM
$ADMA getting the volume up would give a little confirmation.
0 · Reply
ThommyBuy
ThommyBuy Aug. 17 at 3:00 AM
$ADMA showed my wife our retirement account.
3 · Reply
outlawinvestor1
outlawinvestor1 Aug. 16 at 3:56 PM
$CPRX love finding stocks with great fundamentals and a depressed sp. Look forward to the year ahead! $ACAD $HRMY $LNTH $ADMA
1 · Reply
GoldmanSlaps
GoldmanSlaps Aug. 15 at 6:41 PM
$ADMA what are your guys guess for rev for Q3?
6 · Reply
Comingle
Comingle Aug. 15 at 6:34 PM
$ADMA come on baby
0 · Reply
hakoah
hakoah Aug. 15 at 5:00 PM
$ADMA goupyou MF
0 · Reply
StockBraker
StockBraker Aug. 15 at 4:17 PM
$ADMA Waiting for PT updates from the gang. https://ir.admabiologics.com/analyst-coverage
0 · Reply
Latest News on ADMA
ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

Aug 10, 2025, 9:15 AM EDT - 8 days ago

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

ADMA Biologics: A Better Quarter Than Headline Numbers

Aug 8, 2025, 3:58 PM EDT - 9 days ago

ADMA Biologics: A Better Quarter Than Headline Numbers

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:14 PM EDT - 11 days ago

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 6, 2025, 4:05 PM EDT - 11 days ago

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 7:00 AM EDT - 19 days ago

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

Jun 15, 2025, 4:11 AM EDT - 2 months ago

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

May 9, 2025, 3:54 AM EDT - 3 months ago

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:05 PM EDT - 3 months ago

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:05 PM EDT - 3 months ago

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 30, 2025, 7:00 AM EDT - 3 months ago

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

Apr 28, 2025, 7:00 AM EDT - 4 months ago

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

ADMA Biologics Statement on Tariffs

Apr 7, 2025, 7:00 AM EDT - 4 months ago

ADMA Biologics Statement on Tariffs

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

Mar 21, 2025, 3:04 PM EDT - 5 months ago

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Mar 4, 2025, 1:50 PM EST - 5 months ago

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 6:24 PM EST - 5 months ago

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 3, 2025, 4:05 PM EST - 5 months ago

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

Feb 28, 2025, 7:00 AM EST - 6 months ago

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 25, 2025, 7:00 AM EST - 6 months ago

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

Feb 6, 2025, 1:46 PM EST - 6 months ago

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

Dec 20, 2024, 7:00 AM EST - 8 months ago

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Dec 13, 2024, 5:15 PM EST - 8 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Dec 11, 2024, 6:15 PM EST - 8 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 9, 2024, 5:45 PM EST - 8 months ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

Dec 7, 2024, 5:30 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm

Dec 5, 2024, 2:15 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm

Dec 3, 2024, 3:15 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm

ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV

Dec 2, 2024, 8:30 AM EST - 9 months ago

ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

Dec 1, 2024, 3:15 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 29, 2024, 12:30 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Nov 26, 2024, 11:00 AM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

The Schall Law Firm Wants Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Related Infractions

Nov 25, 2024, 1:00 PM EST - 9 months ago

The Schall Law Firm Wants Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Related Infractions

ADMA Biologics, Inc. Is Being Investigated For Engaging In Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Nov 24, 2024, 2:00 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Engaging In Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Help The Schall Law Firm

Nov 20, 2024, 12:00 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Help The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 18, 2024, 12:45 PM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

Nov 16, 2024, 11:45 AM EST - 9 months ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws

Nov 15, 2024, 1:15 PM EST - 9 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws

Curtfry22
Curtfry22 Aug. 18 at 5:15 PM
$ADMA
1 · Reply
baston
baston Aug. 18 at 4:51 PM
$ADMA
0 · Reply
huma_44
huma_44 Aug. 18 at 2:10 PM
$ADMA added, so cheap after a great ER
0 · Reply
biffermeister
biffermeister Aug. 18 at 2:01 PM
$ADMA getting the volume up would give a little confirmation.
0 · Reply
ThommyBuy
ThommyBuy Aug. 17 at 3:00 AM
$ADMA showed my wife our retirement account.
3 · Reply
outlawinvestor1
outlawinvestor1 Aug. 16 at 3:56 PM
$CPRX love finding stocks with great fundamentals and a depressed sp. Look forward to the year ahead! $ACAD $HRMY $LNTH $ADMA
1 · Reply
GoldmanSlaps
GoldmanSlaps Aug. 15 at 6:41 PM
$ADMA what are your guys guess for rev for Q3?
6 · Reply
Comingle
Comingle Aug. 15 at 6:34 PM
$ADMA come on baby
0 · Reply
hakoah
hakoah Aug. 15 at 5:00 PM
$ADMA goupyou MF
0 · Reply
StockBraker
StockBraker Aug. 15 at 4:17 PM
$ADMA Waiting for PT updates from the gang. https://ir.admabiologics.com/analyst-coverage
0 · Reply
GoldmanSlaps
GoldmanSlaps Aug. 14 at 11:22 PM
$ADMA moon soon
2 · Reply
GoldmanSlaps
GoldmanSlaps Aug. 14 at 7:01 PM
$XBI for this to even be sniffing green today is kind of amazing maybe things really are changing. $ALDX $ADMA $ICU
0 · Reply
T00thDr88
T00thDr88 Aug. 14 at 6:46 PM
$ADMA this was over $17 a year ago! And we are in a much better position than last year. Let’s go $ADMA!!!
0 · Reply
DMoney_10
DMoney_10 Aug. 14 at 2:44 PM
$ICU This period reminds me of buying $ADMA in the $1's before it slowly climbed to the mid $20's from 2021 to 2024. $ICU will see $5+ by the end of 2026 and $10+ by the end of 2027 IMO.
3 · Reply
biffermeister
biffermeister Aug. 14 at 2:24 PM
$ADMA into some sept 17's.
0 · Reply
KabX
KabX Aug. 14 at 1:31 PM
$ADMA 📈
0 · Reply
StockBraker
StockBraker Aug. 14 at 12:26 PM
$ADMA
0 · Reply
ncost1
ncost1 Aug. 14 at 12:19 PM
$ADMA rise mdf rise
0 · Reply
RoacHK1LLaH420
RoacHK1LLaH420 Aug. 13 at 6:36 PM
$TNXP $PLTR $HOOD $ADMA 💪🤑😎🍺🍻🇺🇲🇺🇲🤣😂 SETH, SETH, SETH....
1 · Reply
biffermeister
biffermeister Aug. 13 at 6:19 PM
$ADMA sold the 16's for a decent trade. will be looking for another entry. vix is now under 15 so opportunity awaits. that gap fill to 18.5 won't be easy.
1 · Reply
KabX
KabX Aug. 13 at 5:18 PM
$ADMA One of the best ran biotech companies out there! 📈
0 · Reply
ncost1
ncost1 Aug. 13 at 4:40 PM
$ADMA if I do the math correctly we can realistically have retained earnings near 1.5 billion by 2030. Means a lot of money to do whatever we want with. Note they authorized up to 500mm in buybacks but they know they can do way more. They knew that they overextended dilution to get to profitability so their plan is to try to lower float and create shareholder value
1 · Reply